Jundishapur Journal of Microbiology

Published by: Kowsar

Occult Hepatitis B Virus Among the Patients With Abnormal Alanine Transaminase

Manoochehr Makvandi 1 , 2 , 3 , * , Niloofar Neisi 3 , Davod Khalafkhany 3 , Kamyar Makvandi 4 , Eskandar Hajiani 5 , Ali Akbar Shayesteh 5 , Abdolrahim Masjedi Zadeh 5 , Amir Hosein Sina 6 , Mojtaba Hamidifard 3 , Mojtaba Rasti 3 , Ehsan Aryan 7 , Kambiz Ahmadi 8 and Mohammad Jafar Yad Yad 9
Authors Information
1 Infectious and Tropical Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Research Institute for Infectious Diseases of Digestive System, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Virology Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Gastroenterology and Hepatology Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
6 Pathology Unit, Danesh Laboratory, Tehran, IR Iran
7 Antimicrobial Resistance Research Center, Department of Medical Microbiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
8 Department of Statistics, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
9 Department of Education Development Center, Ahvaz Jundishapur of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: August 01, 2014, 7 (8); e11648
  • Published Online: July 13, 2014
  • Article Type: Research Article
  • Received: April 19, 2013
  • Revised: June 25, 2013
  • Accepted: July 14, 2013
  • DOI: 10.5812/jjm.11648

To Cite: Makvandi M, Neisi N, Khalafkhany D, Makvandi K, Hajiani E, et al. Occult Hepatitis B Virus Among the Patients With Abnormal Alanine Transaminase, Jundishapur J Microbiol. 2014 ; 7(8):e11648. doi: 10.5812/jjm.11648.

Abstract
Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997; 337(24): 1733-45[DOI][PubMed]
  • 2. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002; 2(7): 395-403[PubMed]
  • 3. Kao JH, Chen PJ, Chen DS. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. Adv Cancer Res. 2010; 108: 21-72[DOI][PubMed]
  • 4. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3): 225-31[PubMed]
  • 5. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008; 8(4): 281-94
  • 6. Adibi P, Rezailashkajani M, Roshandel D, Behrouz N, Ansari S, Somi MH, et al. An economic analysis of premarriage prevention of hepatitis B transmission in Iran. BMC Infect Dis. 2004; 4: 31[DOI][PubMed]
  • 7. Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A. Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996; 2(2): 290-8
  • 8. Schaefer S. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol. 2007; 13(1): 14-21[PubMed]
  • 9. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004; 47(6): 289-309[DOI][PubMed]
  • 10. Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: Recent advances. J Gastroenterol Hepatol. 2011; 26 Suppl 1: 123-30[DOI][PubMed]
  • 11. Phung TB, Alestig E, Nguyen TL, Hannoun C, Lindh M. Genotype X/C recombinant (putative genotype I) of hepatitis B virus is rare in Hanoi, Vietnam--genotypes B4 and C1 predominate. J Med Virol. 2010; 82(8): 1327-33[DOI][PubMed]
  • 12. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009; 83(20): 10538-47[DOI][PubMed]
  • 13. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008; 49(4): 652-7[DOI][PubMed]
  • 14. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology. 2004; 127(5): 1356-71[PubMed]
  • 15. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat. 2002; 9(4): 243-57[PubMed]
  • 16. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007; 46(1): 160-70[DOI][PubMed]
  • 17. Berasain C, Betes M, Panizo A, Ruiz J, Herrero JI, Civeira MP, et al. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut. 2000; 47(3): 429-35[PubMed]
  • 18. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 2001; 34(1): 194-203[DOI][PubMed]
  • 19. Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol. 2005; 34 Suppl 1-21[PubMed]
  • 20. Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, et al. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study. J Viral Hepat. 2009; 16(6): 437-43[DOI][PubMed]
  • 21. Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012; 25(1): 142-63[DOI][PubMed]
  • 22. Shavakhi A, Norinayer B, Esteghamat FS, Seghatoleslami M, Khodadustan M, Somi MH, et al. Occult hepatitis B among Iranian hepatitis C patients. J Res Med Sci. 2009; 14(1): 13-7[PubMed]
  • 23. Keyvani H, Agah S, Kabir A, Alavian SM. Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study. Ann Hepatol. 2013; 12(2): 213-9[PubMed]
  • 24. Arababadi MK, Pourfath EM, Jafarzadeh A, Hasanshahi GH, Afrouz M, Hadadian M. Occult HBV infection in Rafsanjanese blood donors. Modares J Med Sci . 2008;
  • 25. Sitnik R, Pinho JR, Bertolini DA, Bernardini AP, Da Silva LC, Carrilho FJ. Hepatitis B virus genotypes and precore and core mutants in Brazilian patients. J Clin Microbiol. 2004; 42(6): 2455-60[DOI][PubMed]
  • 26. Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology. 2000; 31(2): 488-95[DOI][PubMed]
  • 27. Raimondo G, Pollicino T, Romano L, Zanetti AR. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris). 2010; 58(4): 254-7[DOI][PubMed]
  • 28. Kumar GT, Kazim SN, Kumar M, Hissar S, Chauhan R, Basir SF, et al. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. J Gastroenterol Hepatol. 2009; 24(4): 588-98[DOI][PubMed]
  • 29. Banerjee A, Kurbanov F, Datta S, Chandra PK, Tanaka Y, Mizokami M, et al. Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J Med Virol. 2006; 78(9): 1164-74[DOI][PubMed]
  • 30. Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M, Saadat A, et al. Hepatitis B virus genotype in Iranian patients with hepatocellular carcinoma. Int J Infect Dis. 2009; 13(6): 685-9[DOI][PubMed]
  • 31. Amini-Bavil-Olyaee S, Alavian SM, Adeli A, Sarrami-Forooshani R, Sabahi F, Sabouri E, et al. Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report. J Med Virol. 2006; 78(3): 358-64[DOI][PubMed]
  • 32. Alfaresi M, Elkoush A, Alshehhi H, Alzaabi A, Islam A. Hepatitis B virus genotypes and precore and core mutants in UAE patients. Virol J. 2010; 7: 160[DOI][PubMed]
  • 33. Ali M, Idrees M, Ali L, Hussain A, Ur Rehman I, Saleem S, et al. Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes. Virol J. 2011; 8: 102[DOI][PubMed]
  • 34. Jain P, Nijhawan S. Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients. World J Gastroenterol. 2008; 14(14): 2288-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments